Home

Torches Suppression Masse dmmr colon cancer distillation aérien Intégrer

Impact of mismatch repair or microsatellite status on the prognosis and  efficacy to chemotherapy in metastatic colorectal cancer patients: A  bi-institutional, propensity score-matched study
Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study

High Response Rate With Neoadjuvant Anti-PD-1 in Localized dMMR Colorectal  Cancer | MedPage Today
High Response Rate With Neoadjuvant Anti-PD-1 in Localized dMMR Colorectal Cancer | MedPage Today

Immunotherapy in colorectal cancer: current achievements and future  perspective
Immunotherapy in colorectal cancer: current achievements and future perspective

An example of early-stage dMMR type 2 colorectal cancer stained with... |  Download Scientific Diagram
An example of early-stage dMMR type 2 colorectal cancer stained with... | Download Scientific Diagram

Frontiers | Lynch Syndrome and MSI-H Cancers: From Mechanisms to  “Off-The-Shelf” Cancer Vaccines
Frontiers | Lynch Syndrome and MSI-H Cancers: From Mechanisms to “Off-The-Shelf” Cancer Vaccines

Final KEYNOTE 177 overall survival data for MSI-H/dMMR metastatic  colorectal cancer - Onco Americas
Final KEYNOTE 177 overall survival data for MSI-H/dMMR metastatic colorectal cancer - Onco Americas

Understanding MSI-High and DNA Mismatch Repair - CancerConnect
Understanding MSI-High and DNA Mismatch Repair - CancerConnect

Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch  repair–deficient, locally advanced rectal cancer | Signal Transduction and  Targeted Therapy
Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer | Signal Transduction and Targeted Therapy

Molecular strategy to distinguish LS-related from sporadic MSI/dMMR... |  Download Scientific Diagram
Molecular strategy to distinguish LS-related from sporadic MSI/dMMR... | Download Scientific Diagram

Cancers | Free Full-Text | Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High  Gastrointestinal Cancers: A Changing Paradigm
Cancers | Free Full-Text | Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm

Cancer du côlon dMMR : changement de paradigme
Cancer du côlon dMMR : changement de paradigme

MSI-H Biomarker | Colorectal Cancer Alliance
MSI-H Biomarker | Colorectal Cancer Alliance

Advances in immune therapies for the treatment of microsatellite  instability‑high/deficient mismatch repair metastatic colorectal cancer  (Review)
Advances in immune therapies for the treatment of microsatellite instability‑high/deficient mismatch repair metastatic colorectal cancer (Review)

ESMO | Press Release | preoperative immunotherapy colon cancer
ESMO | Press Release | preoperative immunotherapy colon cancer

Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From  bench to bedside. - Abstract - Europe PMC
Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside. - Abstract - Europe PMC

In patients with dMMR or MSI-H-positive tumors, multiple mutations... |  Download Scientific Diagram
In patients with dMMR or MSI-H-positive tumors, multiple mutations... | Download Scientific Diagram

Current Oncology | Free Full-Text | Developments in Checkpoint Inhibitor  Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer
Current Oncology | Free Full-Text | Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer

Purpose
Purpose

Final Results Support Pembrolizumab as Standard of Care in MSI-H/dMMR  Metastatic Colorectal Cancer - Cancer Therapy Advisor
Final Results Support Pembrolizumab as Standard of Care in MSI-H/dMMR Metastatic Colorectal Cancer - Cancer Therapy Advisor

Cancers | Free Full-Text | Immune-Checkpoint Inhibitors (ICIs) in  Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite  Instability
Cancers | Free Full-Text | Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability

ESMO22 Highlights on neoadjuvant ICI in locally advanced dMMR colon cancer:  The NICHE-2 study - YouTube
ESMO22 Highlights on neoadjuvant ICI in locally advanced dMMR colon cancer: The NICHE-2 study - YouTube

VisualAbstract: Pembrolizumab linked to longer cancer-free period in  advanced MSI-H-dMMR colorectal cancer | 2 Minute Medicine
VisualAbstract: Pembrolizumab linked to longer cancer-free period in advanced MSI-H-dMMR colorectal cancer | 2 Minute Medicine